Integrated metabolomic-lipidomic profiling reveals novel biomarkers and therapeutic targets for alcohol use disorder with cognitive impairment

Integrated metabolomic-lipidomic profiling reveals novel biomarkers and therapeutic targets for alcohol use disorder with cognitive impairment

PurposeAlcohol use disorder (AUD) is a chronic relapsing condition frequently complicated by cognitive impairment (CI), yet its underlying metabolic mechanisms remain poorly understood. This study aimed to identify plasma metabolic signatures and dysregulated pathways associated with AUD-CI using an...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Shi, Xiaofang Chen, Bojie Zhou, Shanghao Yang, Qinglin Ou, Xuhui Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Psychiatry
Subjects:
alcohol use disorder
cognitive impairment
metabolomics
lipidomics
sphingolipid metabolism
mTORC1 pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1594313/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items